UCSF-led study alerts transwomen and physicians to interpret standard screening guidelines with caution.
Transgender women on hormone therapy tend to skew artificially low on prostate cancer screening tests, which may give false reassurance and delay diagnosis and treatment,…
[ad_2]
Source link
